查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1995240

乳房切片器材市场：2026年至2032年全球市场预测（依产品类型、手术类型、技术、类别、应用、最终用户和分销管道划分）

Breast Biopsy Device Market by Product, Procedure Type, Technique, Category, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，乳房切片设备市场价值将达到 24.2 亿美元，到 2026 年将成长至 25.7 亿美元，到 2032 年将达到 38.1 亿美元，复合年增长率为 6.70%。

主要市场统计数据
基准年 2025 24.2亿美元
预计年份：2026年 25.7亿美元
预测年份 2032 38.1亿美元
复合年增长率 (%) 6.70%

过去十年，影像技术和流程的进步从根本上改变了乳房病变的诊断方法。临床医生现在透过将高解析度成像与微创切片检查相结合，优化了诊断准确性，从而减轻了患者的不适感，并简化了临床流程。早期检测策略不再局限于传统的乳房X光摄影；断层合成、超音波和磁振造影（MRI）引导技术的整合，开启了标靶治疗的新时代，并提高了病变的识别率和组织特征分析能力。

同时，医疗设备製造商正在增加各种切片穿刺针、引导系统以及相关产品，例如立体定位导线和手术台，以支援复杂的手术操作。从纯手动设备向自动化系统的转变，凸显了临床环境中工作流程精简和可重复化的整体趋势。随着对病患安全的日益重视，产品设计现在更加重视人体工学、即时回馈以及与数位影像网路的兼容性。

本执行摘要概述了影响乳房切片设备行业的关键趋势。它概述了变革性的技术变革，评估了监管和贸易趋势的影响，检验了特定细分领域的洞察，分析了区域和竞争格局，并提出了策略建议。其目的是帮助决策者深入了解产业现状，并专注于创新和投资能够带来最大临床和商业性回报的可行领域。

乳房切片技术的重大模式转移以及临床实践的演变，重新定义了患者的治疗结果、效率和准确性。

临床医生和产业领袖正见证着乳房切片手术计画和实施方式的模式转移。超音波和断层合成引导的广泛应用减少了对立体定位平台的依赖，从而能够更精准地定位触诊不到的病灶，并提高诊断准确性。同时，磁振造影（MRI）引导技术对于高风险患者而言已变得至关重要，它能够提供无与伦比的软组织对比度，并可靠地触及深部和后部病灶。

评估近期美国关税对切片检查设备製造商供应链成本结构和竞争力的广泛影响。

美国当局将于2025年对医疗设备零件征收新关税，这给切片检查设备製造商和医疗服务提供者带来了新的挑战。依赖特种合金和微加工导向零件的供应商正面临不断上涨的投入成本压力，被迫重新评估其全球筹资策略。为此，一些设备製造商正在加速向国内生产转型，或在贸易环境更有利的地区寻找替代零件供应商。

对产品类型、流程类型、技术、类别、应用和最终用户群进行详细和全面的分析，以获得策略见解。

透过按类型评估产品，我们可以更深入地了解设备性能和用户需求的细微差别。这包括专为生物标记分析定制的检测试剂盒、针对组织取样优化的各种切片穿刺针、便于患者定位的可定制治疗床、集成多种成像模式的先进导航系统以及用于精确标记病灶的精密定位导丝。每个产品类型都对应诊断工作流程的不同阶段，凸显了整个治疗生态系统相容性和互通性的重要性。

区域展望：美洲、欧洲、中东和非洲以及亚太地区的独特需求因素、机会和挑战

美洲地区的趋势反映了其完善的医疗基础设施，完善的报销机制和大规模筛检计画推动了影像导引切片检查解决方案的快速普及。在美国，高手术量和医生对微创手术的强烈偏好引领了自动化真空辅助系统和先进导引系统的应用。同时，拉丁美洲市场虽然对价格较为敏感，但随着即时检测的推进，对携带式超音波引导设备的需求也不断增长。

领先设备製造商的策略概况和创新蓝图，协助其在乳房切片领域获得竞争优势

乳房切片设备领域的主要企业正利用其在研发方面的策略性投资，推出新一代采样工具和更完善的数位化工作流程。拥有全面诊断产品组合的成熟企业集团正在将其切片检查平台与云端影像管理系统集成，以实现无缝资料交换和远距离诊断支援。与这些功能丰富的产品线形成对比的是，还有一些设备创新者专注于特定应用领域，例如相容MRI的切片穿刺针和快速现场评估试剂盒。

针对製造商、医疗保健提供者和投资者，提出具体的策略建议，以抓住乳房切片。

为巩固市场地位，製造商应优先开发整合影像引导、自动化和数位化报告功能的平台。透过让产品蓝图与临床医生的工作流程和电子健康记录系统保持一致，企业可​​以降低产品推广门槛，并在手术效率和诊断准确性方面展现显着价值。同时，增加对培训计画和模拟教学的投入，将进一步提升使用者技能，并有助于建立更牢固的客户关係。

采用综合性的多元方法研究方法，结合一手质性访谈、二手资讯和严格的检验过程。

本研究采用多方面方法，结合了对乳房摄影专家、介入性放射科医师和外科肿瘤医师的深入定性访谈。透过全面审查这些主要发现以及同行评审期刊、监管文件和专业学会指南，确保了临床和科学的严谨性。研究还运用了来自多个资讯来源的资料点进行三角验证，以检验手术流程趋势、设备采用率和区域部署模式。

整合关键洞察，突显创新采纳、市场变化、监管趋势以及相关人员。

在先进成像、自动化采样和数位分析工具融合的推动下，乳房切片设备市场格局正以惊人的速度演变。微创技术的普及减轻了患者的负担，同时也提高了诊断的可靠性。同时，全球贸易趋势和关税结构的变化迫使相关人员重新评估其供应链策略和区域伙伴关係。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：乳房切片设备市场：依产品划分

  • 检测试剂盒
  • 切片穿刺针
  • 切片检查
  • 导航系统
  • 定位线

第九章：依手术类型分類的乳房切片设备市场

  • 核心针穿刺切片
  • 细针穿刺切片检查
  • 穿刺辅助切片检查

第十章：乳房切片设备市场：依技术划分

  • 磁共振引导
  • 立体定位
  • 断层合成引导系统
  • 超音波引导

第十一章：乳房切片设备市场：按类别划分

  • 自动切片检查装置
  • 手动切片检查装置

第十二章乳房切片设备市场：依应用领域划分

  • 良性病变的诊断
  • 恶性病变的诊断

第十三章乳房切片设备市场：依最终用户划分

  • 门诊手术中心
  • 诊断影像中心
  • 医院

第十四章乳房切片设备市场：依分销管道划分

  • 线下销售
  • 线上销售

第十五章：乳房切片设备市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章乳房切片设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章乳房切片设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章：美国乳房切片设备市场

第十九章：中国乳房切片设备市场

第20章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Advin Health Care
  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Company
  • Cook Group Incorporated
  • Danaher Corporation
  • FUJIFILM Corporation
  • General Electric Company
  • Halma plc
  • Hologic, Inc
  • INRAD Inc.
  • Medline Industries, LP
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Ningbo Xinwell Medical Technology Co., LTD.
  • PAJUNK GmbH
  • Planmeca Oy
  • Point Blank Medical
  • Siemens AG
  • SNVL Varay Laborix
  • STERYLAB Srl
  • Suretech Medical Inc.
  • Thermo Fisher Scientific Inc.
  • Trivitron Healthcare
  • Vector Medical, Inc.
  • Zamar Care
Product Code: MRR-807A20B5CD96

The Breast Biopsy Device Market was valued at USD 2.42 billion in 2025 and is projected to grow to USD 2.57 billion in 2026, with a CAGR of 6.70%, reaching USD 3.81 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.42 billion
Estimated Year [2026] USD 2.57 billion
Forecast Year [2032] USD 3.81 billion
CAGR (%) 6.70%

Over the past decade, advancements in imaging modalities and procedural techniques have fundamentally altered the approach to diagnosing breast lesions. Clinicians now combine high-resolution visualization with minimally invasive sampling to optimize diagnostic precision, reducing patient discomfort and streamlining care pathways. Early detection strategies are no longer confined to standard mammography; the integration of tomosynthesis, ultrasound, and magnetic resonance guidance has ushered in a new era of targeted interventions that improve lesion localization and tissue characterization.

In parallel, device manufacturers have expanded their portfolios to include a diverse array of biopsy needles, guidance systems, and ancillary products such as localization wires and tables that support complex procedures. The transition from purely manual devices to automated systems underscores a broader trend toward workflow efficiency and reproducibility in clinical settings. With an increased focus on patient safety, product designs now prioritize ergonomics, real-time feedback, and compatibility with digital imaging networks.

This executive summary synthesizes the critical trends shaping the breast biopsy device domain. It outlines transformative technological shifts, assesses the impact of regulatory and trade dynamics, examines segment-specific insights, evaluates regional and competitive landscapes, and presents strategic recommendations. The goal is to equip decision-makers with a nuanced understanding of the industry's trajectory and to highlight actionable areas where innovation and investment can yield the greatest clinical and commercial returns.

Key Paradigm Shifts in Breast Biopsy Technologies and Evolving Clinical Practices Redefining Patient Outcomes Efficiency and Precision

Clinicians and industry leaders alike are witnessing a paradigm shift in how breast biopsy procedures are planned and executed. The widespread adoption of ultrasonography and tomosynthesis guidance has reduced reliance on stereotactic platforms, enabling more precise targeting of non-palpable lesions and augmenting diagnostic yield. Concurrently, magnetic resonance guided techniques have become indispensable for high-risk patients, offering unparalleled soft-tissue contrast and the ability to access deep or posterior lesions with confidence.

Beyond imaging, the transition from core needle and fine needle aspiration to vacuum assisted biopsy systems reflects an emphasis on obtaining larger tissue volumes while minimizing sampling error. This shift has been accompanied by the development of next-generation biopsy needles that leverage advanced tip geometries and hydrophilic coatings to reduce insertion force and improve specimen integrity. These enhancements have translated into fewer needle passes, shorter procedure times, and a lower incidence of patient discomfort.

Artificial intelligence and artificial vision technologies are now being integrated into guidance platforms to assist with lesion segmentation and needle path planning. Such digital augmentation not only accelerates decision-making in the procedure room but also supports telemedicine applications, enabling remote expert consultation in real time. As a result, service providers are redefining care models to deliver faster turnarounds and more personalized diagnostic experiences, heralding a new chapter in precision breast health management.

Evaluating the Broad Effects of Recent United States Tariffs on the Supply Chain Cost Structures and Competitive Dynamics of Biopsy Device Manufacturers

The imposition of new tariffs on imported medical device components by United States authorities in 2025 has introduced a fresh layer of complexity for biopsy device manufacturers and healthcare providers. Suppliers reliant on specialized alloys and microfabricated guidance parts have experienced upward pressure on input costs, prompting a reevaluation of global sourcing strategies. In response, some device makers have accelerated their shift toward domestic production or have sought alternative component suppliers in trade-friendly regions.

Pricing adjustments have rippled through procurement budgets at ambulatory surgery centers, diagnostic imaging centers, and hospital systems, leading to more vigorous price negotiations and, in certain instances, the delayed adoption of premium biopsy tables and guidance systems. Simultaneously, manufacturers with in-house vertical integration have demonstrated greater resilience, securing operational continuity while maintaining tighter control over cost structures. These firms have been better positioned to weather the tariff-induced disruptions and to preserve customer relationships through value-added service agreements.

Looking ahead, the threat of additional trade measures has underscored the importance of cross-border regulatory alignment and the cultivation of dual-sourcing networks. Strategic partnerships between device innovators and regional contract manufacturing organizations have gained momentum as a means to safeguard supply chain robustness. Ultimately, the 2025 tariff landscape has reinforced the critical interplay between geopolitical factors and clinical technology deployment, shaping the competitive dynamics of the biopsy device domain.

In-Depth Comprehensive Analysis of Product Procedure Type Technique Category Application and End User Segments for Targeted Strategic Insights

A nuanced understanding of device performance and user requirements emerges when assessments are segmented by product type, encompassing offerings such as assay kits tailored for biomarker analysis, a range of biopsy needles optimized for tissue capture, customizable procedure tables that facilitate patient positioning, advanced guidance systems that integrate imaging modalities, and precision localization wires designed for accurate lesion marking. Each product category addresses a distinct phase of the diagnostic workflow, underscoring the importance of compatibility and interoperability across the procedural ecosystem.

Procedural segmentation reveals that core needle biopsy remains a mainstay for sampling both palpable and non-palpable masses, while fine needle aspiration continues to serve in cytology-driven contexts where minimal tissue disruption is paramount. Vacuum assisted biopsy has gained traction among clinicians seeking larger specimens and lower repeat rates, with automated devices offering consistent sampling profiles that reduce user dependency.

Technique-based differentiation highlights the growing prevalence of MRI guided interventions in high-complexity cases, juxtaposed with the ubiquity of ultrasound guided methods in routine screenings and diagnostic follow-ups. Tomosynthesis guided biopsies have emerged as a hybrid approach, delivering three-dimensional lesion visualization with lower radiation exposure than traditional stereotactic guidance.

From a device category perspective, automated systems are increasingly favored for their reproducibility and workflow integration, while manual devices retain their appeal in resource-constrained settings and mobile screening units. Applications span the spectrum from benign lesion diagnosis, where rapid turnover and cost-effectiveness are prioritized, to malignant lesion diagnosis, which demands the highest levels of sampling accuracy and tissue integrity. End user considerations further differentiate demand across ambulatory surgery centers known for efficiency, diagnostic imaging centers valued for specialized expertise, and hospitals that accommodate complex case mixes. Finally, distribution channels bifurcate into offline sales, driven by established procurement processes, and online sales, which have gained momentum through digital catalogues and e-commerce portals.

Regional Outlook Revealing Unique Demand Drivers Opportunities and Challenges Across the Americas Europe Middle East Africa and Asia Pacific

Regional dynamics in the Americas reflect a consolidated healthcare infrastructure, where reimbursement frameworks and large-scale screening programs have catalyzed the rapid uptake of image-guided biopsy solutions. The United States leads in the adoption of automated vacuum assisted and advanced guidance systems, driven by high procedure volumes and strong physician preferences for minimally invasive approaches. Meanwhile, Latin American markets, though more price-sensitive, are showing growing demand for portable ultrasound guided devices that align with point-of-care testing initiatives.

In Europe, Middle East and Africa, heterogeneity in healthcare funding and regulatory pathways influences the diffusion of new technologies. Western Europe's mature reimbursement environment supports the integration of tomosynthesis and MRI guided platforms, whereas parts of the Middle East are investing heavily in cutting-edge facilities to serve medical tourism sectors. African regions with limited infrastructure tend to adopt manual and cost-effective biopsy needles, although pilot programs in tertiary centers are testing more sophisticated guidance equipment.

The Asia Pacific region is characterized by dynamic growth, propelled by rising breast cancer awareness and expanding public healthcare expenditure. Emerging economies are prioritizing the deployment of ultrasound guided systems in community hospitals, while advanced markets in Japan and Australia emphasize precision imaging and the standardization of biopsy protocols. Local manufacturing initiatives and government-sponsored screening drives are shaping regional procurement strategies, underscoring the importance of scalable solutions that align with diverse clinical and economic environments.

Strategic Profiles and Innovation Roadmaps of Leading Device Manufacturers Driving Competitive Edge in the Breast Biopsy Space

Leading participants in the breast biopsy device space are leveraging strategic investments in research and development to introduce next-generation sampling tools and digital workflow enhancements. Established conglomerates with comprehensive diagnostic portfolios are integrating biopsy platforms with cloud-enabled image management systems, enabling seamless data exchange and remote diagnostic support. These feature-rich offerings are contrasted by specialized device innovators focusing on niche applications such as MRI compatible biopsy needles and rapid on-site evaluation kits.

Mergers and partnerships have become instrumental in expanding technological capabilities, with several key players forming alliances with software providers to embed artificial intelligence modules into guidance consoles. These collaborations emphasize real-time lesion detection and adaptive needle trajectory optimization, setting the stage for reduced procedural variability and improved clinical confidence. At the same time, smaller regional manufacturers are targeting cost-effective device designs tailored to emerging economies, fostering competitive pricing dynamics and expanding access to basic image-guided biopsy services.

Intellectual property portfolios further delineate competitive positioning, as patents covering proprietary needle tip geometries and automation algorithms block new entrants from replicating critical design features. Service contracts and recurring consumables also serve as anchors for customer loyalty, creating recurring revenue streams that support continuous innovation. Collectively, these strategic moves are reshaping the competitive landscape, with innovation velocity and integrated digital solutions emerging as the primary differentiators among industry leaders.

Targeted Strategic Recommendations for Manufacturers Healthcare Providers and Investors to Seize Opportunities and Mitigate Risks in the Breast Biopsy Sector

Manufacturers aiming to solidify their presence should prioritize the development of integrated platforms that combine imaging guidance, automation, and digital reporting functionalities. By aligning product roadmaps with clinician workflows and electronic medical record systems, companies can reduce adoption barriers and demonstrate clear value in procedure efficiency and diagnostic accuracy. Parallel investments in training programs and simulation-based education will further support user proficiency and foster stronger customer relationships.

Healthcare providers are encouraged to evaluate device portfolios holistically, considering not only upfront acquisition costs but also long-term service agreements, consumable consumptions, and potential for integration with existing imaging networks. Engaging with multiple suppliers to pilot emerging technologies can reveal best-fit solutions for specific patient populations and facility requirements. Embracing flexible procurement models, such as pay-per-use or outcome-based contracts, may also mitigate budgetary pressures and accelerate technology adoption.

Investors and industry partners should seek opportunities in regions where screening initiatives are scaling rapidly and regulatory environments are adapting more quickly to digital health solutions. Strategic collaborations with local contract manufacturers and clinical centers can de-risk market entry and facilitate the development of tailored offerings. By focusing on segments with high unmet clinical needs, such as MRI guided biopsy systems for dense breast tissue, stakeholders can position themselves at the forefront of emerging growth corridors.

Comprehensive Multimethod Research Approach Integrating Primary Qualitative Interviews Secondary Data Sources and Rigorous Triangulation Processes

This research employed a multimethod approach combining in-depth qualitative interviews with leading breast imaging specialists, interventional radiologists, and surgical oncologists. These primary insights were complemented by a comprehensive review of peer-reviewed journals, regulatory filings, and professional society guidelines to ensure clinical and scientific rigor. Data points were triangulated across multiple sources to validate procedural trends, device adoption rates, and regional deployment patterns.

Secondary research included an analysis of regulatory databases for device approvals and import-export records to quantify the influence of trade policies. Intellectual property landscapes were mapped using patent registries, while corporate financial statements and investor presentations provided context on strategic priorities and R&D investments. Market intelligence from healthcare conferences and expert panels informed the identification of emerging technologies and ecosystem partnerships.

Throughout the research process, all findings were subjected to peer review by an external advisory board comprising clinicians and industry consultants. This iterative validation step enhanced the reliability of conclusions and ensured that the final report delivers actionable insights grounded in the latest clinical practices and commercial realities.

Synthesis of Critical Findings Underscoring Innovation Adoption Market Shifts Regulatory Developments and Strategic Imperatives for Stakeholders

The breast biopsy device landscape is evolving at a remarkable pace, driven by the convergence of advanced imaging, automated sampling, and digital analysis tools. The shift toward minimally invasive procedures is reducing patient burden while elevating diagnostic confidence. Simultaneously, global trade dynamics and tariff structures are compelling stakeholders to rethink supply chain strategies and regional partnerships.

Segment-driven insights reveal that product innovation must be tailored to distinct clinical workflows, from rapid cytology in aspiration procedures to high-throughput vacuum assisted systems. Regional patterns underscore the necessity of adaptable solutions that address both resource-rich and resource-constrained environments, highlighting the opportunity for scalable device architectures.

Competitive intensity is shaped by a blend of deep-pocketed multinationals integrating AI capabilities and agile niche players customizing cost-effective offerings for localized markets. Future success will hinge on the ability to harmonize technological advancements with streamlined service models, supported by robust training and digital integration. These strategic imperatives will guide industry participants as they navigate an increasingly complex and opportunity-rich clinical milieu.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Breast Biopsy Device Market, by Product

  • 8.1. Assay Kits
  • 8.2. Biopsy Needles
  • 8.3. Biopsy Tables
  • 8.4. Guidance Systems
  • 8.5. Localization Wires

9. Breast Biopsy Device Market, by Procedure Type

  • 9.1. Core Needle Biopsy
  • 9.2. Fine Needle Aspiration
  • 9.3. Vacuum Assisted Biopsy

10. Breast Biopsy Device Market, by Technique

  • 10.1. MRI Guided
  • 10.2. Stereotactic
  • 10.3. Tomosynthesis Guided
  • 10.4. Ultrasound Guided

11. Breast Biopsy Device Market, by Category

  • 11.1. Automated Biopsy Devices
  • 11.2. Manual Biopsy Devices

12. Breast Biopsy Device Market, by Application

  • 12.1. Benign Lesion Diagnosis
  • 12.2. Malignant Lesion Diagnosis

13. Breast Biopsy Device Market, by End User

  • 13.1. Ambulatory Surgery Centers
  • 13.2. Diagnostic Imaging Centers
  • 13.3. Hospitals

14. Breast Biopsy Device Market, by Distribution Channel

  • 14.1. Offline Sales
  • 14.2. Online Sales

15. Breast Biopsy Device Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Breast Biopsy Device Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Breast Biopsy Device Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Breast Biopsy Device Market

19. China Breast Biopsy Device Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Advin Health Care
  • 20.6. Argon Medical Devices, Inc.
  • 20.7. Becton, Dickinson and Company
  • 20.8. Cook Group Incorporated
  • 20.9. Danaher Corporation
  • 20.10. FUJIFILM Corporation
  • 20.11. General Electric Company
  • 20.12. Halma plc
  • 20.13. Hologic, Inc
  • 20.14. INRAD Inc.
  • 20.15. Medline Industries, LP
  • 20.16. Medtronic PLC
  • 20.17. Merit Medical Systems, Inc.
  • 20.18. Ningbo Xinwell Medical Technology Co., LTD.
  • 20.19. PAJUNK GmbH
  • 20.20. Planmeca Oy
  • 20.21. Point Blank Medical
  • 20.22. Siemens AG
  • 20.23. SNVL Varay Laborix
  • 20.24. STERYLAB S.r.l.
  • 20.25. Suretech Medical Inc.
  • 20.26. Thermo Fisher Scientific Inc.
  • 20.27. Trivitron Healthcare
  • 20.28. Vector Medical, Inc.
  • 20.29. Zamar Care

LIST OF FIGURES

  • FIGURE 1. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BREAST BIOPSY DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BREAST BIOPSY DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY TABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY TABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY TABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY LOCALIZATION WIRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY LOCALIZATION WIRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY LOCALIZATION WIRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CORE NEEDLE BIOPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CORE NEEDLE BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CORE NEEDLE BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY VACUUM ASSISTED BIOPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY VACUUM ASSISTED BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY VACUUM ASSISTED BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MRI GUIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MRI GUIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MRI GUIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY STEREOTACTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY STEREOTACTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY STEREOTACTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TOMOSYNTHESIS GUIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TOMOSYNTHESIS GUIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TOMOSYNTHESIS GUIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY AUTOMATED BIOPSY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY AUTOMATED BIOPSY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY AUTOMATED BIOPSY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MANUAL BIOPSY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MANUAL BIOPSY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MANUAL BIOPSY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BENIGN LESION DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BENIGN LESION DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BENIGN LESION DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MALIGNANT LESION DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MALIGNANT LESION DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MALIGNANT LESION DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY OFFLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY OFFLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY OFFLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 148. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 150. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 151. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. GCC BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 172. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 174. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 175. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. G7 BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 180. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 182. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 183. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. NATO BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA BREAST BIOPSY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)